Global Pharmaceutical Grade Non-animal-derived Sodium Hyaluronate Gel Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Pharmaceutical Grade Non-animal-derived Sodium Hyaluronate Gel Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Sodium hyaluronate is the sodium salt of hyaluronic acid. Sodium hyaluronate, as a glycosaminoglycan, exists in the extracellular matrix of many connective tissues and the cornea in the human body. It is composed of D-glucuronic acid and N-acetyl-D-glucosamine. Artificial extraction of Streptococcus epidemics fermentation broth. Sodium hyaluronate and its solution are mostly used in ophthalmology and orthopedic surgery, providing support for surgical instruments and providing lubrication and cushioning for soft tissue joints. It is also widely used for beauty purposes, and is added to various cosmetics to improve the skin's water retention effect and relieve wrinkles.
Pharmaceutical Grade Non-animal-derived Sodium Hyaluronate Gel report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Pharmaceutical Grade Non-animal-derived Sodium Hyaluronate Gel market is projected to reach US$ 866 million in 2029, increasing from US$ 652.4 million in 2022, with the CAGR of 4.1% during the period of 2024 to 2029. Demand from Eye Surgery and Orthopedic Surgery are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Pharmaceutical Grade Non-animal-derived Sodium Hyaluronate Gel industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Pharmaceutical Grade Non-animal-derived Sodium Hyaluronate Gel key manufacturers include B. Braun Melsungen, CryoLife, GluStitch, Ethicon, Chemence, Bausch & Lomb-Freda, Scapa Healthcare, Bostik and Henkel AG & Company, etc. B. Braun Melsungen, CryoLife, GluStitch are top 3 players and held % sales share in total in 2022.
Pharmaceutical Grade Non-animal-derived Sodium Hyaluronate Gel can be divided into 0.25ml/Stem, 0.5ml/Stem, 0.75ml/Stem and 1ml/Stem, etc. 0.25ml/Stem is the mainstream product in the market, accounting for % sales share globally in 2022.
Pharmaceutical Grade Non-animal-derived Sodium Hyaluronate Gel is widely used in various fields, such as Eye Surgery, Orthopedic Surgery, Intra-articular Injection and Gynecological Surgery, etc. Eye Surgery provides greatest supports to the Pharmaceutical Grade Non-animal-derived Sodium Hyaluronate Gel industry development. In 2022, global % sales of Pharmaceutical Grade Non-animal-derived Sodium Hyaluronate Gel went into Eye Surgery filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Pharmaceutical Grade Non-animal-derived Sodium Hyaluronate Gel market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
B. Braun Melsungen
CryoLife
GluStitch
Ethicon
Chemence
Bausch & Lomb-Freda
Scapa Healthcare
Bostik
Henkel AG & Company
Meyer-Haake Gmbh
Baxter International
Cyberbond
Segment by Type
0.25ml/Stem
0.5ml/Stem
0.75ml/Stem
1ml/Stem
1.25ml/Stem
1.5ml/Stem
Others
Eye Surgery
Orthopedic Surgery
Intra-articular Injection
Gynecological Surgery
Cosmetic Surgery
Others
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Pharmaceutical Grade Non-animal-derived Sodium Hyaluronate Gel market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Pharmaceutical Grade Non-animal-derived Sodium Hyaluronate Gel, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Pharmaceutical Grade Non-animal-derived Sodium Hyaluronate Gel industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Pharmaceutical Grade Non-animal-derived Sodium Hyaluronate Gel in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Pharmaceutical Grade Non-animal-derived Sodium Hyaluronate Gel introduction, etc. Pharmaceutical Grade Non-animal-derived Sodium Hyaluronate Gel Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Pharmaceutical Grade Non-animal-derived Sodium Hyaluronate Gel market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Pharmaceutical Grade Non-animal-derived Sodium Hyaluronate Gel report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Pharmaceutical Grade Non-animal-derived Sodium Hyaluronate Gel market is projected to reach US$ 866 million in 2029, increasing from US$ 652.4 million in 2022, with the CAGR of 4.1% during the period of 2024 to 2029. Demand from Eye Surgery and Orthopedic Surgery are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Pharmaceutical Grade Non-animal-derived Sodium Hyaluronate Gel industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Pharmaceutical Grade Non-animal-derived Sodium Hyaluronate Gel key manufacturers include B. Braun Melsungen, CryoLife, GluStitch, Ethicon, Chemence, Bausch & Lomb-Freda, Scapa Healthcare, Bostik and Henkel AG & Company, etc. B. Braun Melsungen, CryoLife, GluStitch are top 3 players and held % sales share in total in 2022.
Pharmaceutical Grade Non-animal-derived Sodium Hyaluronate Gel can be divided into 0.25ml/Stem, 0.5ml/Stem, 0.75ml/Stem and 1ml/Stem, etc. 0.25ml/Stem is the mainstream product in the market, accounting for % sales share globally in 2022.
Pharmaceutical Grade Non-animal-derived Sodium Hyaluronate Gel is widely used in various fields, such as Eye Surgery, Orthopedic Surgery, Intra-articular Injection and Gynecological Surgery, etc. Eye Surgery provides greatest supports to the Pharmaceutical Grade Non-animal-derived Sodium Hyaluronate Gel industry development. In 2022, global % sales of Pharmaceutical Grade Non-animal-derived Sodium Hyaluronate Gel went into Eye Surgery filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Pharmaceutical Grade Non-animal-derived Sodium Hyaluronate Gel market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
B. Braun Melsungen
CryoLife
GluStitch
Ethicon
Chemence
Bausch & Lomb-Freda
Scapa Healthcare
Bostik
Henkel AG & Company
Meyer-Haake Gmbh
Baxter International
Cyberbond
Segment by Type
0.25ml/Stem
0.5ml/Stem
0.75ml/Stem
1ml/Stem
1.25ml/Stem
1.5ml/Stem
Others
Segment by Application
Eye Surgery
Orthopedic Surgery
Intra-articular Injection
Gynecological Surgery
Cosmetic Surgery
Others
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Pharmaceutical Grade Non-animal-derived Sodium Hyaluronate Gel market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Pharmaceutical Grade Non-animal-derived Sodium Hyaluronate Gel, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Pharmaceutical Grade Non-animal-derived Sodium Hyaluronate Gel industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Pharmaceutical Grade Non-animal-derived Sodium Hyaluronate Gel in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Pharmaceutical Grade Non-animal-derived Sodium Hyaluronate Gel introduction, etc. Pharmaceutical Grade Non-animal-derived Sodium Hyaluronate Gel Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Pharmaceutical Grade Non-animal-derived Sodium Hyaluronate Gel market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices